(Q54685330)

2 June 2018

title

Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563388

9 October 2022

1 reference

F. Sarubbi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563388

9 October 2022

B. Franzus

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563388

9 October 2022

A. Verghese

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563388

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1563388

9 October 2022

publication date

1 January 1992

1 reference

2 June 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

2 June 2018

volume

11

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

65-68

1 reference

2 June 2018

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

Multicenter in vitro evaluation of SM-7338, a new carbapenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01971276

In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1563388

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01971276

1 reference

2 June 2018

1 reference

2 June 2018